[The association of lexotan + propantheline in the treatment of functional gastrointestinal disorders. Controlled clinical study].
D000328:Adult; D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001960:Bromazepam / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011413:Propantheline / Q000627:therapeutic use*; D011602:Psychophysiologic Disorders / Q000188:drug therapy*
D014151:Anti-Anxiety Agents; D004338:Drug Combinations; D011413:Propantheline; C029947:Lexil; D001960:Bromazepam
L'associazione lexotan + propantelina nei disturbi gastroenterici funzionali. Studio clinico controllato.